PharVision Advisers’s Loar Holdings LOAR Stock Holding History

PharVision Advisers’s Portfolio LOAR Stock Details LOAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,727	Closed	-$218K	–	1052
2025 Q3	$218K	Buy	+2,727	New	+$205K	0.12%	438

Other funds holding LOAR

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

PharVision Advisers's LOAR Position: Q4 2025 in Review

PharVision Advisers sold out of Loar Holdings (LOAR) in Q4 2025, closing a stake of 2,727 shares — an estimated $218K sold.

PharVision Advisers first reported a position in LOAR in Q3 2025 and held it in 1 quarter. The position peaked at $218K in Q3 2025. 241 funds tracked by Wall St. Rank hold LOAR as of Q4 2025.

PharVision Advisers reported no remaining Loar Holdings position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 2,727 Loar Holdings shares in Q4 2025, an estimated $218K.
PharVision Advisers first reported a position in Loar Holdings in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Loar Holdings position peaked at $218K in Q3 2025.
241 funds tracked by Wall St. Rank held Loar Holdings as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.